Elisabeth Krömer

1.4k total citations
16 papers, 1.1k citations indexed

About

Elisabeth Krömer is a scholar working on Molecular Biology, Hematology and Immunology. According to data from OpenAlex, Elisabeth Krömer has authored 16 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Hematology and 5 papers in Immunology. Recurrent topics in Elisabeth Krömer's work include Multiple Myeloma Research and Treatments (6 papers), Glycosylation and Glycoproteins Research (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Elisabeth Krömer is often cited by papers focused on Multiple Myeloma Research and Treatments (6 papers), Glycosylation and Glycoproteins Research (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Elisabeth Krömer collaborates with scholars based in Austria, France and Slovakia. Elisabeth Krömer's co-authors include Johannes Drach, R. Heinz, Heinz Gisslinger, Niklas Zojer, Heinz Ludwig, H. Huber, Jutta Ackermann, E. Fritz, H. Kaufmann and Robert Königsberg and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Elisabeth Krömer

16 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elisabeth Krömer Austria 12 583 582 324 203 202 16 1.1k
RJ Berenson United States 10 870 1.5× 286 0.5× 317 1.0× 253 1.2× 381 1.9× 16 1.2k
R Kay Canada 8 373 0.6× 366 0.6× 232 0.7× 200 1.0× 378 1.9× 10 994
SH Bartelmez United States 16 666 1.1× 409 0.7× 318 1.0× 253 1.2× 428 2.1× 26 1.2k
Masaaki Takatoku Japan 18 658 1.1× 528 0.9× 323 1.0× 327 1.6× 135 0.7× 47 1.1k
George F. Barker United States 6 924 1.6× 713 1.2× 260 0.8× 470 2.3× 166 0.8× 7 1.6k
WM Roberts United States 12 348 0.6× 367 0.6× 285 0.9× 112 0.6× 263 1.3× 19 1.0k
T Skórski United States 15 600 1.0× 792 1.4× 338 1.0× 384 1.9× 156 0.8× 31 1.5k
Marie‐Paule Mellerin France 14 472 0.8× 415 0.7× 346 1.1× 176 0.9× 195 1.0× 18 871
Paula Fukushima United States 13 268 0.5× 319 0.5× 474 1.5× 119 0.6× 367 1.8× 17 1.1k
D. Rill United States 8 545 0.9× 550 0.9× 445 1.4× 140 0.7× 215 1.1× 10 1.3k

Countries citing papers authored by Elisabeth Krömer

Since Specialization
Citations

This map shows the geographic impact of Elisabeth Krömer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabeth Krömer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabeth Krömer more than expected).

Fields of papers citing papers by Elisabeth Krömer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabeth Krömer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabeth Krömer. The network helps show where Elisabeth Krömer may publish in the future.

Co-authorship network of co-authors of Elisabeth Krömer

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabeth Krömer. A scholar is included among the top collaborators of Elisabeth Krömer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabeth Krömer. Elisabeth Krömer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Vanura, Katrina, Trang Le, Harald Esterbauer, et al.. (2008). Autoimmune conditions and chronic infections in chronic lymphocytic leukemia patients at diagnosis are associated with unmutated IgVH genes. Haematologica. 93(12). 1912–1916. 20 indexed citations
2.
Kaufmann, H., Elisabeth Krömer, Thomas Nösslinger, et al.. (2003). Both chromosome 13 abnormalities by metaphase cytogenetics and deletion of 13q by interphase FISH only are prognostically relevant in multiple myeloma. European Journal Of Haematology. 71(3). 179–183. 24 indexed citations
3.
Königsberg, Robert, J Ackermann, H. Kaufmann, et al.. (2000). Deletions of chromosome 13q in monoclonal gammopathy of undetermined significance. Leukemia. 14(11). 1975–1979. 55 indexed citations
4.
Zojer, Niklas, Robert Königsberg, Jutta Ackermann, et al.. (2000). Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence in situ hybridization. Blood. 95(6). 1925–1930. 226 indexed citations
5.
Königsberg, Robert, Niklas Zojer, Jutta Ackermann, et al.. (2000). Predictive Role of Interphase Cytogenetics for Survival of Patients With Multiple Myeloma. Journal of Clinical Oncology. 18(4). 804–804. 115 indexed citations
6.
Kandioler, Daniela, Elisabeth Krömer, Heinz Tüchler, et al.. (1998). Long-Term Results After Repeated Surgical Removal of Pulmonary Metastases. The Annals of Thoracic Surgery. 65(4). 909–912. 128 indexed citations
7.
Drach, Johannes, Jutta Ackermann, E. Fritz, et al.. (1998). Presence of a p53 Gene Deletion in Patients With Multiple Myeloma Predicts for Short Survival After Conventional-Dose Chemotherapy. Blood. 92(3). 802–809. 239 indexed citations
8.
Drach, Johannes, Jutta Ackermann, E. Fritz, et al.. (1998). Presence of a p53 Gene Deletion in Patients With Multiple Myeloma Predicts for Short Survival After Conventional-Dose Chemotherapy. Blood. 92(3). 802–809. 10 indexed citations
9.
Reischl, Ilona, et al.. (1996). Function and regulation of Fc epsilon RI expression on monocytes from non-atopic donors.. PubMed. 26(6). 630–41. 31 indexed citations
10.
Pfeilstöcker, Michael, Elisabeth Krömer, Borislava G. Pavlova, et al.. (1996). Expression of G alpha 16, a G-protein alpha subunit specific for hematopoiesis in acute leukemia.. PubMed. 10(7). 1117–21. 9 indexed citations
11.
Reischl, Ilona, et al.. (1996). Function and regulation of FcεRI expression on monocytes from non‐atopic donors. Clinical & Experimental Allergy. 26(6). 630–641. 24 indexed citations
12.
Krömer, Elisabeth, et al.. (1994). Cloning of a Locusta cDNA encoding a precursor peptide for two structurally related proteinase inhibitors. Insect Biochemistry and Molecular Biology. 24(3). 329–331. 25 indexed citations
13.
Krömer, Elisabeth, et al.. (1994). Light scatter based lymphocyte gate–helpful tool or source of error?. Cytometry. 15(1). 87–89. 7 indexed citations
14.
Agis, Hermine, Martin Willheim, Wolfgang R. Sperr, et al.. (1993). Monocytes do not make mast cells when cultured in the presence of SCF. Characterization of the circulating mast cell progenitor as a c- kit +, CD34+, Ly-, CD14-, CD17-, colony-forming cell.. The Journal of Immunology. 151(8). 4221–4227. 106 indexed citations
15.
Lagueux, Marie, Elisabeth Krömer, & Josiane Girardie. (1992). Cloning of a Locusta cDNA encoding neuroparsin A. Insect Biochemistry and Molecular Biology. 22(6). 511–516. 23 indexed citations
16.
Katinger, Hermann, W Scheirer, & Elisabeth Krömer. (1978). Der Blasensäulenfermenter für die Massensuspensionskultur tierischer Zellen. Chemie Ingenieur Technik. 50(6). 472–473. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026